|
Jan 28
|
2 Under-the-Radar Stocks With Incredible Upside Potential
|
|
Jan 15
|
3 Biotech Stocks You Can Buy and Hold for the Next Decade
|
|
Jan 13
|
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week
|
|
Jan 12
|
Recursion’s Chris Gibson on AI in biotech and ‘virtuous cycles’
|
|
Jan 11
|
40 Cities with the Lowest Life Expectancy in the US
|
|
Dec 29
|
Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 20,054 Shares
|
|
Dec 22
|
40 Cities with the Highest Life Expectancy in the US
|
|
Dec 20
|
Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry
|
|
Dec 15
|
Insider Sell: CFO Michael Secora Sells 50,000 Shares of Recursion Pharmaceuticals Inc (RXRX)
|
|
Dec 14
|
Recursion Pharmaceuticals Stock (NASDAQ:RXRX): Small Company, Big Future
|
|
Dec 9
|
Insider Sell: CEO Christopher Gibson Disposes of 59,829 Shares of Recursion Pharmaceuticals Inc ...
|
|
Nov 28
|
Cathie Wood picks up nearly 2 million shares of struggling, cheap stock
|
|
Nov 26
|
Recursion Pharmaceuticals Wants to 4X Its Supercomputing Power for AI With the Help of Nvidia. Here's Why It Matters.
|
|
Nov 2
|
Recursion to Participate in Upcoming Investor Conference
|
|
Sep 12
|
Cathie Wood Pours Millions Into These 2 Beaten-Down Stocks, Analysts Say They Could Be Ready to Bounce Back — Here’s Why You Should Take Notice
|
|
Sep 12
|
2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall Street
|
|
Sep 11
|
Where Will Recursion Pharmaceuticals Be in 3 Years?
|
|
Sep 9
|
CEO Christopher Gibson Sells 58,765 Shares of Recursion Pharmaceuticals Inc (RXRX)
|
|
Sep 6
|
2 Brilliant Growth Stocks With Upsides of About 70%, According to Wall Street
|
|
Aug 25
|
Better AI Biotech Stock: Recursion Pharmaceuticals vs. 23andMe
|